• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳氟化合物气溶胶推进剂X:二氯四氟乙烷在犬体内的药代动力学

Fluorocarbon aerosol propellants X: pharmacokinetics of dichlorotetrafluoroethane in dogs.

作者信息

Niazi S, Chiou W L

出版信息

J Pharm Sci. 1976 Jan;65(1):60-4. doi: 10.1002/jps.2600650111.

DOI:10.1002/jps.2600650111
PMID:1255437
Abstract

An intravenous dosage form of dichlorotetrafluoroethane, a common fluorocarbon aerosol propellant, was formulated in polyethylene glycol 400 for single dosing to unanesthetized dogs. A three-compartment open model was proposed for the disposition of this compound in dogs, with average half-lives of 1.3, 9.6, and 50.8 min for the three disposition phases. An analysis of tissue compartment distribution following a single dose showed that it took about 2 hr to achieve pseudo-distribution equilibration, following which more than 90% of the propellant remaining in the body was retained in the tissue compartments. Pulmonary clearance and volumes of distribution were calculated considering the first-pass effect through the lungs. The volume of distribution was approximately 10 times the body weight in terms of blood concentration, and about 84% of the propellant was cleared from the blood passing through the lungs in each cycle.

摘要

一种常见的氟碳气雾剂推进剂二氯四氟乙烷的静脉剂型,以聚乙二醇400配制,用于对未麻醉的犬单次给药。提出了一个三室开放模型来描述该化合物在犬体内的处置过程,三个处置阶段的平均半衰期分别为1.3、9.6和50.8分钟。单次给药后组织隔室分布分析表明,大约需要2小时才能达到伪分布平衡,此后体内剩余的推进剂中超过90%保留在组织隔室中。考虑到通过肺部的首过效应,计算了肺部清除率和分布容积。就血药浓度而言,分布容积约为体重的10倍,每个循环中约84%的推进剂从流经肺部的血液中清除。

相似文献

1
Fluorocarbon aerosol propellants X: pharmacokinetics of dichlorotetrafluoroethane in dogs.碳氟化合物气溶胶推进剂X:二氯四氟乙烷在犬体内的药代动力学
J Pharm Sci. 1976 Jan;65(1):60-4. doi: 10.1002/jps.2600650111.
2
Fluorocarbon aerosol propellants IV: pharmacokinetics of trichloromonofluoromethane following single and multiple dosing in dogs.碳氟化合物气雾剂推进剂IV:犬单次及多次给药后一氟三氯甲烷的药代动力学
J Pharm Sci. 1975 May;64(5):763-9. doi: 10.1002/jps.2600640507.
3
Fluorocarbon aerosol propellants XI: Pharmacokinetics of dichlorodifluoromethane in dogs following single and multiple dosing.碳氟化合物气雾剂推进剂十一:单剂量和多剂量给药后犬体内二氯二氟甲烷的药代动力学
J Pharm Sci. 1977 Jan;66(1):49-53. doi: 10.1002/jps.2600660111.
4
Fluorocarbon aerosol propellants. VI: Interspecies differences in solubilities in blood and plasma and their possible implications in toxicity studies.碳氟化合物气溶胶推进剂。VI:血液和血浆中溶解度的种间差异及其在毒性研究中的潜在意义。
J Pharm Sci. 1975 Sep;64(9):1538-41. doi: 10.1002/jps.2600640926.
5
Fluorocarbon aerosol propellants XII: Correlation of blood level of trichloromonofluoromethane to cardiovascular and respiratory responses in anesthetized dogs.碳氟化合物气溶胶推进剂十二:麻醉犬体内三氯一氟甲烷血药浓度与心血管及呼吸反应的相关性
J Pharm Sci. 1979 Feb;68(2):160-3. doi: 10.1002/jps.2600680210.
6
Toxicology of haloalkane propellants and fire extinguishants.卤代烷推进剂和灭火剂的毒理学
Annu Rev Pharmacol Toxicol. 1977;17:83-95. doi: 10.1146/annurev.pa.17.040177.000503.
7
Cryoanalgesia with dichlorotetrafluoroethane spray versus ice packs in patients treated with botulinum toxin-a for palmar hyperhidrosis: Self-controlled study.用二氯四氟乙烷喷雾剂与冰袋进行冷冻镇痛治疗肉毒杆菌毒素A治疗的手掌多汗症患者:自身对照研究。
Dermatol Surg. 2006 Jun;32(6):873-4. doi: 10.1111/j.1524-4725.2006.32181.x.
8
Study on the binding of trichloromonofluoromethane by bovine serum albumin using a fluorescent probe technique.采用荧光探针技术研究牛血清白蛋白与三氯一氟甲烷的结合作用。
Pharmacology. 1976;14(1):58-66. doi: 10.1159/000136580.
9
Determination of fluorinated hydrocarbon propellants in blood of dogs after aerosol administration.雾化给药后犬血液中氟化烃推进剂的测定。
J Pharm Sci. 1972 Sep;61(9):1445-9. doi: 10.1002/jps.2600610920.
10
Apparent volume of distribution, pulmonary clearance and bioavailability of volatile or gaseous compounds after peripheral intravenous dosing.外周静脉给药后挥发性或气态化合物的表观分布容积、肺清除率和生物利用度。
Res Commun Chem Pathol Pharmacol. 1974 Apr;7(4):679-86.

引用本文的文献

1
Compartment- and model-independent linear plateau principle of drugs during a constant-rate absorption or intravenous infusion.
J Pharmacokinet Biopharm. 1980 Jun;8(3):311-8. doi: 10.1007/BF01059648.
2
Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.
J Pharmacokinet Biopharm. 1979 Oct;7(5):527-36. doi: 10.1007/BF01062393.